Evidence map›Paper›PMID 29931469›Full record

ArticleVirchows Archiv : an international journal of pathology2018

Cytogenetic and immunohistochemical study of 42 pigmented microcystic chromophobe renal cell carcinoma (PMChRCC).

Francisco Javier Queipo Gutiérrez, Ángel Panizo, Antonio Tienza, Irene Rodriguez, Jesús Javier Sola, Jordi Temprana-Salvador, Inés de Torres, Javier Pardo-Mindán

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 1 country.

Francisco Javier Queipo GutiérrezHospital San Jorge, Avenida Martínez de Velasco no. 36, 22004, Huesca, Spain. patxiqueipo@gmail.com.
Ángel PanizoComplejo Hospitalario de Navarra, Calle Irunlarrea no. 3, 31008, Pamplona, Spain.
Antonio TienzaHospital Universitario Son Espases, Carr. de Valldemossa, 79, Palma, Islas Baleares, Spain.
Irene RodriguezHospital Universitario HM Puerta del Sur, Móstoles, Avenida Carlos V, no. 70, 28938, Móstoles, Spain.
Jesús Javier SolaHospital San Pedro, Logroño, Calle Piqueras, 98, 26006, Logroño, La Rioja, Spain.
Jordi Temprana-SalvadorHospital Universitario Vall D'Hebron, Passeig de la Vall d'Hebron, 119-129, 08035, Barcelona, Spain.
Inés de TorresHospital Universitario Vall D'Hebron, Passeig de la Vall d'Hebron, 119-129, 08035, Barcelona, Spain.
Javier Pardo-MindánUniversidad de Navarra, Calle Irunlarrea no. 1, 31008, Pamplona, Spain.
Vall d'Hebron Hospital Universitari · ESComplejo Hospitalario de Navarra · ESHospital General San Jorge · ESHospital San Pedro · ESHospital Universitario Son Espases · ESUniversidad de Navarra · ESUniversity Hospital HM Puerta del Sur · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pigmented microcystic chromophobe renal cell carcinoma (PMChRCC) is a recently described morphologic variant of ChRCC. We have identified 42 cases in 40 patients in the last 24 years. We have investigated their clinical, morphologic, immunohistochemical, and cytogenetic features. Chromosomal abnormalities of chromosomes 7 and 17 were evaluated by automated dual-color silver-enhanced in situ hybridization on paraffin-embedded tissue. Chromosomal imbalance was defined on the basis of changes in both chromosomal index and signal distribution. The main age was 60.20 years, being 34 males and 6 women. The mean tumor diameter was 4.84 cm, with 39 intrarenal tumors. Grossly, the tumors were solid with a brown dark colored. Microscopically, tumors consisted of pale and eosinophilic cells arranged in microcysts or microalveolar in a cribriform pattern; there were microcalcifications and a dark brown pigment, mostly extracellular. One case showed sarcomatoid transformation. All tumors were positive for epithelial membrane antigen (EMA), Claudin 7, and E-cadherin. Monosomy of 7 and 17 chromosomes was present in 1/36 cases and 2/37 cases, respectively. Polysomy of chromosome 7 and 17 was found in 26/36 cases and in 4/37, respectively. With a median follow-up of 74.05 months, 37 patients were alive without disease and two were alive with disease progression. PMChRCCs expand the morphologic spectrum of the ChRCC with an unusual immunohistochemical profile. Cytogenetically, they showed monosomy to chromosome (CHR) 17 as other ChRCCs and polysomy of CHR 7 infrequent to ChRCCs. We present the probably largest series of PMCRCC, confirming their low aggressive behavior, with exceptional sarcomatoid transformation and distant metastases.

Indexed as

Biomarkers, TumorImmunohistochemistryIn Situ HybridizationAdultAgedAged, 80 and overCarcinoma, Renal CellChromosomes, Human, Pair 17Chromosomes, Human, Pair 7Diagnosis, DifferentialFemaleGenetic Predisposition to DiseaseHumansKidney NeoplasmsMaleMiddle AgedBiomarkers, TumorChromophobe pigmentedCytogeneticMicrocysticRenal carcinomaSISH

Identifiers

PMID29931469
OpenAlexW2809623702

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.